Skip to main content
Top
Published in: Journal of Gastroenterology 12/2012

01-12-2012 | Original Article—Liver, Pancreas, and Biliary Tract

High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: differentiation between benignity and malignancy

Authors: Takahisa Ogawa, Jun Horaguchi, Naotaka Fujita, Yutaka Noda, Go Kobayashi, Kei Ito, Shinsuke Koshita, Yoshihide Kanno, Kaori Masu, Reiji Sugita

Published in: Journal of Gastroenterology | Issue 12/2012

Login to get access

Abstract

Background

Recently, the clinical application of diffusion-weighted magnetic resonance imaging (DWI) has been expanding to abdominal organs. However, only a few studies on gallbladder diseases have been published. The aim of this study was to evaluate the usefulness and limitations of high b-value DWI for gallbladder diseases.

Methods

A total of 153 patients (mean age 60 ± 15 years, 78 males) who had undergone DWI for evaluating gallbladder wall thickening or polypoid lesions were included in this study. Of these 153 patients, 36 had gallbladder cancer and 117 had benign gallbladder diseases (67 chronic cholecystitis, 44 adenomyomatosis, four cholesterol polyp, one gallbladder adenoma, and one xanthogranulomatous cholecystitis). We evaluated the positive signal rate with DWI and the apparent diffusion coefficient (ADC) value of each disease.

Results

The positive signal rate with DWI was significantly higher in gallbladder cancer (78 %) than in benign gallbladder diseases (22 %) (p < 0.001). The mean ADC value of gallbladder cancer was (1.83 ± 0.69) × 10−3 mm2/s and that of benign gallbladder diseases was (2.60 ± 0.54) × 10−3 mm2/s (p < 0.001). Benign gallbladder diseases with acute cholecystitis or a history of that had a higher positive signal rate with DWI (p < 0.001) and a lower ADC value (p = 0.018) than those without such conditions.

Conclusion

DWI can contribute to the improvement of the diagnostic capability for gallbladder wall thickening or polypoid lesions by compensating for weaknesses of other modalities by its many advantages, although cases with acute cholecystitis or such history sometimes show false-positive on DWI.
Literature
1.
go back to reference Kimura K, Fujita N, Noda Y, Kobayashi G, Ito K. Differential diagnosis of large-sized pedunculated polypoid lesions of the gallbladder by endoscopic ultrasonography: a prospective study. J Gastroenterol. 2001;36:619–22.PubMedCrossRef Kimura K, Fujita N, Noda Y, Kobayashi G, Ito K. Differential diagnosis of large-sized pedunculated polypoid lesions of the gallbladder by endoscopic ultrasonography: a prospective study. J Gastroenterol. 2001;36:619–22.PubMedCrossRef
2.
go back to reference Kaza RK, Gulati M, Wig JD, Chawla YK. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol. 2006;50:212–7.PubMedCrossRef Kaza RK, Gulati M, Wig JD, Chawla YK. Evaluation of gall bladder carcinoma with dynamic magnetic resonance imaging and magnetic resonance cholangiopancreatography. Australas Radiol. 2006;50:212–7.PubMedCrossRef
3.
go back to reference Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluorodeoxyglucose (FDG-PET). J Surg Oncol. 2003;84:74–81.PubMedCrossRef Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluorodeoxyglucose (FDG-PET). J Surg Oncol. 2003;84:74–81.PubMedCrossRef
4.
go back to reference Ching BH, Yeh BM, Westphalen AC, Joe BN, Qayyum A, Coakley FV. CT differentiation of adenomyomatosis and gallbladder cancer. AJR Am J Roentgenol. 2007;189:62–6.PubMedCrossRef Ching BH, Yeh BM, Westphalen AC, Joe BN, Qayyum A, Coakley FV. CT differentiation of adenomyomatosis and gallbladder cancer. AJR Am J Roentgenol. 2007;189:62–6.PubMedCrossRef
5.
go back to reference Kim SJ, Lee JM, Lee JY, Kim SH, Han JK, Choi BI, et al. Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis. AJR Am J Roentgenol. 2008;191:765–71.PubMedCrossRef Kim SJ, Lee JM, Lee JY, Kim SH, Han JK, Choi BI, et al. Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis. AJR Am J Roentgenol. 2008;191:765–71.PubMedCrossRef
6.
go back to reference Liang JL, Chen MC, Huang HY, Nq SH, Sheen-Chen SM, Liu PP, et al. Gallbladder carcinoma manifesting as acute cholecystitis: clinical and computed tomographic features. Surgery. 2009;146:861–8.PubMedCrossRef Liang JL, Chen MC, Huang HY, Nq SH, Sheen-Chen SM, Liu PP, et al. Gallbladder carcinoma manifesting as acute cholecystitis: clinical and computed tomographic features. Surgery. 2009;146:861–8.PubMedCrossRef
7.
go back to reference Jang JY, Kim SW, Lee SE, Hwang DW, Kim EJ, Lee JY, et al. Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer. Ann Surg. 2009;250:943–9.PubMedCrossRef Jang JY, Kim SW, Lee SE, Hwang DW, Kim EJ, Lee JY, et al. Differential diagnostic and staging accuracies of high resolution ultrasonography, endoscopic ultrasonography, and multidetector computed tomography for gallbladder polypoid lesions and gallbladder cancer. Ann Surg. 2009;250:943–9.PubMedCrossRef
8.
go back to reference Uchiyama K, Ozawa S, Ueno M, Hayami S, Hirono S, Ina S, et al. Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:333–8.PubMedCrossRef Uchiyama K, Ozawa S, Ueno M, Hayami S, Hirono S, Ina S, et al. Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:333–8.PubMedCrossRef
9.
go back to reference Goshima S, Chang S, Wang JH, Kanematsu M, Bae KT, Federle MP. Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol. 2010;74:e79–83.PubMedCrossRef Goshima S, Chang S, Wang JH, Kanematsu M, Bae KT, Federle MP. Xanthogranulomatous cholecystitis: diagnostic performance of CT to differentiate from gallbladder cancer. Eur J Radiol. 2010;74:e79–83.PubMedCrossRef
10.
go back to reference Kimura K, Fujita N, Noda Y, Kobayashi G, Ito K, Horaguchi J, et al. Localized wall thickening of the gallbladder mimicking a neoplasm. Dig Endosc. 2004;16:54–7.CrossRef Kimura K, Fujita N, Noda Y, Kobayashi G, Ito K, Horaguchi J, et al. Localized wall thickening of the gallbladder mimicking a neoplasm. Dig Endosc. 2004;16:54–7.CrossRef
11.
go back to reference Makino I, Yamaguchi T, Sato N, Yasui T, Kita I. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol. 2009;15:3691–3.PubMedCrossRef Makino I, Yamaguchi T, Sato N, Yasui T, Kita I. Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET. World J Gastroenterol. 2009;15:3691–3.PubMedCrossRef
12.
go back to reference Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–7.PubMed Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–7.PubMed
13.
go back to reference Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. Am J Gastroenterol. 2006;187:1521–30. Yoshikawa T, Kawamitsu H, Mitchell DG, Ohno Y, Ku Y, Seo Y, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. Am J Gastroenterol. 2006;187:1521–30.
14.
go back to reference Chan JH, Tsui EY, Luk SH, Fung AS, Yuen MK, Szeto ML, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging. 2001;26:161–5.PubMedCrossRef Chan JH, Tsui EY, Luk SH, Fung AS, Yuen MK, Szeto ML, et al. Diffusion-weighted MR imaging of the liver: distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging. 2001;26:161–5.PubMedCrossRef
15.
go back to reference Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799–806.PubMedCrossRef Taouli B, Tolia AJ, Losada M, Babb JS, Chan ES, Bannan MA, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799–806.PubMedCrossRef
16.
go back to reference Ichikawa T, Erturk SM, Motosugi U, Sou H, Iino H, Araki T, et al. High b-value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 2007;188:409–14.PubMedCrossRef Ichikawa T, Erturk SM, Motosugi U, Sou H, Iino H, Araki T, et al. High b-value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol. 2007;188:409–14.PubMedCrossRef
17.
go back to reference Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, et al. High b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging. 2009;30:1005–11.PubMedCrossRef Muhi A, Ichikawa T, Motosugi U, Sano K, Matsuda M, Kitamura T, et al. High b-value diffusion-weighted MR imaging of hepatocellular lesions: estimation of grade of malignancy of hepatocellular carcinoma. J Magn Reson Imaging. 2009;30:1005–11.PubMedCrossRef
18.
go back to reference Akisik MF, Aisen AM, Sandrasegaran K, Jenninqs SG, Lin C, Sherman S, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250:103–9.PubMedCrossRef Akisik MF, Aisen AM, Sandrasegaran K, Jenninqs SG, Lin C, Sherman S, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology. 2009;250:103–9.PubMedCrossRef
19.
go back to reference Kamisawa T, Takuma K, Anjiki H, Egawa N, Hata T, Kurata M, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol. 2010;105:1870–5.PubMedCrossRef Kamisawa T, Takuma K, Anjiki H, Egawa N, Hata T, Kurata M, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol. 2010;105:1870–5.PubMedCrossRef
20.
go back to reference Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging. 2010;32:138–47.PubMedCrossRef Miller FH, Hammond N, Siddiqi AJ, Shroff S, Khatri G, Wang Y, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging. 2010;32:138–47.PubMedCrossRef
21.
go back to reference Wang Y, Chen ZE, Nikolaidis P, McCarthy RJ, Merrick L, Sternick LA, et al. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging. 2011;33:136–42.PubMedCrossRef Wang Y, Chen ZE, Nikolaidis P, McCarthy RJ, Merrick L, Sternick LA, et al. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging. 2011;33:136–42.PubMedCrossRef
22.
go back to reference Sugita R, Yamazaki T, Furuta A, Itoh K, Fujita N, Takahashi S. High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results. Eur Radiol. 2009;19:1794–8.PubMedCrossRef Sugita R, Yamazaki T, Furuta A, Itoh K, Fujita N, Takahashi S. High b-value diffusion-weighted MRI for detecting gallbladder carcinoma: preliminary study and results. Eur Radiol. 2009;19:1794–8.PubMedCrossRef
23.
go back to reference Irie H, Kamochi N, Nojiri J, Eqashira Y, Sasaquri K, Kudo S. High b-value diffusion-weighted MRI in differentiation between benign and malignant polypoid gallbladder lesions. Acta Radiol. 2011;52:236–40.PubMedCrossRef Irie H, Kamochi N, Nojiri J, Eqashira Y, Sasaquri K, Kudo S. High b-value diffusion-weighted MRI in differentiation between benign and malignant polypoid gallbladder lesions. Acta Radiol. 2011;52:236–40.PubMedCrossRef
24.
go back to reference Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–25.PubMed Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–25.PubMed
25.
go back to reference Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.PubMedCrossRef Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.PubMedCrossRef
26.
go back to reference Cui XY, Chen HW. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol. 2010;16:3196–201.PubMedCrossRef Cui XY, Chen HW. Role of diffusion-weighted magnetic resonance imaging in the diagnosis of extrahepatic cholangiocarcinoma. World J Gastroenterol. 2010;16:3196–201.PubMedCrossRef
27.
go back to reference Imai H, Osada S, Sasaki Y, Ikawa A, Takahashi T, Yamaguchi K, et al. Gallbladder adenocarcinoma with extended intramural spread in adenomyomatosis of the gallbladder with pearl necklace sign. Am Surg. 2011;77:E57–8.PubMed Imai H, Osada S, Sasaki Y, Ikawa A, Takahashi T, Yamaguchi K, et al. Gallbladder adenocarcinoma with extended intramural spread in adenomyomatosis of the gallbladder with pearl necklace sign. Am Surg. 2011;77:E57–8.PubMed
28.
go back to reference Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A, Asayama Y, et al. Well-differentiated adenocarcinoma of the gallbladder with intratumoral cystic components due to abundant mucin production: a mimicker of adenomyomatosis. Eur Radiol. 2005;15:229–33.PubMedCrossRef Yoshimitsu K, Irie H, Aibe H, Tajima T, Nishie A, Asayama Y, et al. Well-differentiated adenocarcinoma of the gallbladder with intratumoral cystic components due to abundant mucin production: a mimicker of adenomyomatosis. Eur Radiol. 2005;15:229–33.PubMedCrossRef
Metadata
Title
High b-value diffusion-weighted magnetic resonance imaging for gallbladder lesions: differentiation between benignity and malignancy
Authors
Takahisa Ogawa
Jun Horaguchi
Naotaka Fujita
Yutaka Noda
Go Kobayashi
Kei Ito
Shinsuke Koshita
Yoshihide Kanno
Kaori Masu
Reiji Sugita
Publication date
01-12-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 12/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-012-0604-1

Other articles of this Issue 12/2012

Journal of Gastroenterology 12/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine